In addition, it has been reported that SFXN2 is present in four different cancer types, namely, kidney cancer, urothelial cancer, cervical cancer, and liver cancer; only for kidney cancer is SFXN2 favourable [31]. This evidence concerns the gene SFXN2 and cervical cancer.